AllergoOncology: Expression platform development and functional profiling of an anti-HER2 IgE antibody. (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/all.13818
PubMed Identifier: 30964550
Publication URI: http://europepmc.org/abstract/MED/30964550
Type: Journal Article/Review
Volume: 74
Parent Publication: Allergy
Issue: 10
ISSN: 0105-4538